Benzinga - by Lisa Levin, Benzinga Editor.
Gainers
- Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.
- Nuvve Holding Corp. (NASDAQ: NVVE) shares climbed 88% to $0.2789 after falling 10% on Tuesday. Nuvve recently announced pricing of a $1 million underwritten public offering of roughly 7 million shares of common stock at a price to the public of $0.14 per share.
- BIO-key International, Inc. (NASDAQ: BKYI) surged 57% to $0.30. BIO-key International reported results for its third quarter ended Sept. 30, 2023.
- ReShape Lifesciences Inc. (NASDAQ: RSLS) gained 44.7% to $0.2976 after gaining over 6% on Tuesday. ReShape Lifesciences recently announced pricing of $3.0 million public offering.
- BioXcel Therapeutics, Inc. (NASDAQ: BTAI) shares climbed 37.6% to $3.2199 after announcing positive findings from an independent third party audit of the data integrity at TRANQUILITY II Phase 3 trial site.
- ParaZero Technologies Ltd. (NASDAQ: PRZO) gained 26% to $2.0350.
- Catalyst Biosciences, Inc. (NASDAQ: CBIO) climbed 18% to $0.5095.
- Scholar Rock Holding Corporation (NASDAQ: SRRK) gained 16.5% to $8.92. Jefferies upgraded Scholar Rock from Hold to Buy and announced a $20 price target.
- Stride, Inc. (NYSE: LRN) rose 16.4% to $51.81 after the company reported first-quarter results.
- OncoCyte Corporation (NASDAQ: OCX) gained 14.4% to $2.86.
- Urgent.ly Inc. (NASDAQ: ULY) surged 14% to $5.01.
- GameSquare Holdings, Inc. (NASDAQ: GAME) gained 13.1% to $2.07.
- Treasure Global Inc. (NASDAQ: TGL) rose 12.8% to $0.4501.
- PROG Holdings, Inc. (NYSE: PRG) rose 9.3% to $31.14 following upbeat quarterly results.
- LumiraDx Limited (NASDAQ: LMDX) gained 8.4% to $0.1680 after dipping around 44% on Tuesday.
- John Bean Technologies Corporation (NYSE: JBT) surged 8.1% to $104.00 after posting strong quarterly earnings.
- Sonendo, Inc. (NYSE: SONX) shares gained 8% to $0.2483 after falling over 23% on Tuesday. Sonendo recently announced preliminary revenue results for the third quarter.
- Crown ElectroKinetics Corp. (NASDAQ: CRKN) climbed 8% to $0.2700.
- Deutsche Bank Aktiengesellschaft (NYSE: DB) rose 6.6% to $10.72 after the company reported a year-over-year increase in third-quarter EPS and sales results.
- Deutsche Bank Aktiengesellschaft (NYSE: DB) gained 6.6% to $10.72 after the company reported a year-over-year increase in third-quarter EPS and sales results.
- The Gap, Inc. (NYSE: GPS) climbed 6.2% to $13.18. Wells Fargo upgraded Gap from Equal-Weight to Overweight and raised the price target from $11 to $16.
- Microsoft Corporation (NASDAQ: MSFT) shares rose 3.7% to $342.72 as the company posted stronger-than-expected results for its fiscal first quarter on Tuesday. Piper Sandler maintained Microsoft with an Overweight and raised the price target from $400 to $425.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Appreciate Holdings, Inc. (NASDAQ: SFR) fell 34% to $0.0980. Appreciate Holdings received a notice from Nasdaq regarding delisting.
- reAlpha Tech Corp. (NASDAQ: AIRE) declined 33.9% to $76.00.
- Vicor Corporation (NASDAQ: VICR) fell 28.7% to $37.88 after reporting results for the third quarter.
- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares fell 28% to $1.3020 as the company reported pricing of $4.55 million underwritten public offering.
- Cibus, Inc. (NASDAQ: CBUS) fell 25.5% to $10.29.
- InMed Pharmaceuticals Inc. (NASDAQ: INM) shares fell 25.2% to $0.74. InMed Pharmaceuticals announced a $5.2 million private placement and preferred investment option exercise priced at-the-market under Nasdaq rules.
- Tharimmune, Inc. (NASDAQ: THAR) shares fell 24.5% to $0.1902 after jumping 34% on Tuesday.
- Yoshiharu Global Co. (NASDAQ: YOSH) dipped 21.9% to $0.4480.
- SemiLEDs Corporation (NASDAQ: LEDS) fell 20.5% to $1.12.
- SunPower Corporation (NASDAQ: SPWR) shares declined 20.3% to $3.9550 as the company announced plans to restate financial statements for affected periods in amendments to Form 10-K, Q1 Form 10-Q, and Q2 2023 Form 10-Q, respectively.
- Motus GI Holdings, Inc. (NASDAQ: MOTS) fell 20% to $0.5358. Motus GI recently received FDA clearance to commercialize Pure-Vu EVS Gastro and Gen 4 Colon.
- Forbion European Acquisition Corp. (NASDAQ: FRBN) declined 19.6% to $14.63.
- Alphatec Holdings, Inc. (NASDAQ: ATEC) shares fell 19.3% to $10.34 after the company priced underwritten public offering of 14.3 million common shares at $10.50 per share.
- Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) fell 18.2% to $1.84. Lipella Pharmaceuticals announced a $2 million private placement priced at-the-market under Nasdaq rules.
- Mountain Crest Acquisition Corp. IV (NASDAQ: MCAF) declined 18.2% to $8.75.
- Intrusion Inc. (NASDAQ: INTZ) shares fell 16.5% to $0.2880 after declining over 7% on Tuesday.
- Energy Recovery, Inc. (NASDAQ: ERII) declined 16.5% to $15.34. Energy Recovery named David Moon as Interim CEO.
- USANA Health Sciences, Inc. (NYSE: USNA) fell 16% to $46.56 following weak quarterly results.
- Enova International, Inc. (NYSE: ENVA) declined 15.4% to $37.38 after the company reported mixed third-quarter financial results.
- The Greenbrier Companies, Inc. (NYSE: GBX) dipped 15.4% to $34.57 after the company reported fourth-quarter results.
- 3D Systems Corporation (NYSE: DDD) fell 14.8% to $3.7552 after the company announced additional restructuring initiative and issued preliminary third quarter financial results.
- Ascent Solar Technologies, Inc. (NASDAQ: ASTI) shares fell 12.5% to $1.0502. Ascent Solar shares jumped 22% on Tuesday after the company announced the initial concept paper submitted for DE-FOA-000305 has been reviewed and received an "Encouraged" decision from the DOE.
- Affirm Holdings, Inc. (NASDAQ: AFRM) fell 12.2% to $17.15 after Compass Point downgraded the stock from Neutral to Sell.
- Life Time Group Holdings, Inc. (NYSE: LTH) declined 12.2% to $12.55 following third-quarter results.
- Marine Products Corporation (NYSE: MPX) fell 11.3% to $11.66 following weak third-quarter results.
- Constellium SE (NASDAQ: CSTM) fell 9.9% to $14.67 following mixed third-quarter results.
- Boyd Gaming Corporation (NYSE: BYD) declined 9.8% to $55.01 following weak third-quarter earnings.
- BOK Financial Corporation (NASDAQ: BOKF) declined 9.6% to $64.68 following weak third-quarter earnings.
- Option Care Health, Inc. (NASDAQ: OPCH) dipped 9.6% to $29.71 following third-quarter results.
- BioVie Inc. (NASDAQ: BIVI) shares fell 9.3% to $3.04 after gaining around 3% on Tuesday.
- IDEAYA Biosciences, Inc. (NASDAQ: IDYA) shares fell 9.3% to $24.73 after the company announced pricing of public offering.
- Stratasys Ltd. (NASDAQ: SSYS) dropped 9.2% to $10.51.
- Nuvei Corporation (NASDAQ: NVEI) declined 9.1% to $14.21.
- Alphabet Inc. (NASDAQ: GOOGL) shares fell 8.8% to $126.64. Alphabet reported better-than-expected earnings and sales results for its third quarter, but recorded downbeat performance for its cloud computing unit.
- Alkermes plc (NASDAQ: ALKS) fell 8.8% to $23.08 after reporting quarterly results.
- Repligen Corporation (NASDAQ: RGEN) declined 8.6% to $127.65.
- Owens Corning (NYSE: OC) fell 8.6% to $112.75 after the company reported worse-than-expected third-quarter revenue results and issued fourth-quarter net sales guidance.
- Cognition Therapeutics, Inc. (NASDAQ: CGTX) shares fell 8.3% to $1.11. Cognition Therapeutics presented complete EEG findings from SEQUEL study of CT1812 in mild-to-moderate Alzheimer's disease at the Clinical Trials on Alzheimer’s Disease (CTAD) conference.
- Automatic Data Processing, Inc. (NASDAQ: ADP) declined 8.2% to $220.76 after the company reported mixed quarterly financial results and reiterated guidance.
- CoStar Group, Inc. (NASDAQ: CSGP) shares fell 7.8% to $68.31 after the company reported worse-than-expected third-quarter sales results and issued FY23 guidance below estimates.
- MarketAxess Holdings Inc. (NASDAQ: MKTX) declined 7.4% to $218.41 following weak sales.
- Teladoc Health, Inc. (NYSE: TDOC) shares fell 5.7% to $17.08 after the company posted downbeat third-quarter sales and issued weak sales forecast for the current quarter.
- Texas Instruments Incorporated (NASDAQ: TXN) shares fell 4.2% to $140.76 after the company reported worse-than-expected third-quarter sales results and issued fourth-quarter revenue guidance below estimates.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.